Print
Q&A
The fact that the budget of the National Institutes of Health has remained stagnant for several years, threatens to drive young researchers into other fields, according to a dire warning issued by a group of leading research universities. Kevin Casey, an organizer of the report, spoke to TJOLS about the flat NIH budget, young researchers who are ready to call it quits, and the prospects for increased federal funding for biomedical research. Read More
RESEARCH:
Lost GenerationHarvard University's Kevin Casey talks about how a stagnant NIH budget threatens to send young researchers searching for new careers.
The fact that the budget of the National Institutes of Health has remained stagnant for several years, threatens to drive young researchers into other fields, according to a dire warning issued by a group of leading research universities. Kevin Casey, an organizer of the report, spoke to TJOLS about the flat NIH budget, young researchers who are ready to call it quits, and the prospects for increased federal funding for biomedical research. Read More
- Lost Generation
Harvard University's Kevin Casey talks about how a stagnant NIH budget threatens to send young researchers searching for new careers.
March 21, 2008 - Law/Policy - Research - Ready for Prime Time
Pacific Growth Equities adds a regenerative medicine analyst to its roster.
January 04, 2008 - Finance - Finance - Shock and Awe
The cost of the war in Iraq has already surpassed the amount spent on the Vietnam War, but the healthcare bill that will follow to care for veterans could total as much as $660 billion.
November 12, 2007 - Health - Public Health - A Funny Thing Happened On The Way To The Forum
Money is flowing more freely into the biotech sector, but investors remain selective as BIO kicks off its annual investor conference.
October 10, 2007 - Finance - Finance - HIV Positive
Epidemiologist Tara Smith says denialists are spreading potentially lethal misinformation about AIDS and the issue points to broader problems of scientific illiteracy in America.
August 24, 2007 - DANIEL S. LEVINE - Society - Culture - Power Shift
Asia is set to become not only the largest pharmaceutical market, but its territories will be important industry hubs.
August 08, 2007 - DANIEL S. LEVINE - Business - Global Economy - Impatient Advocates
Frank Burroughs wants the FDA to allow critically ill patients to have access to experimental drugs before they are approved.
July 30, 2007 - DANIEL S. LEVINE - Tech/Innovation - Bioethics - A Thorn in Pharma's Side
Patent watchdog Dan Ravicher touts the need for patent reform after getting the U.S. government to review Gilead's patents for its leading HIV drug.
July 18, 2007 - DANIEL S. LEVINE - Law/Policy - Regulatory - Case Closed
California's stem cell chairman Robert Klein looks ahead after the state's top court squashes an effort to end funding for research.
May 18, 2007 - Health - Regenerative Medicine - Genentech's Joe McCracken Is On the Hunt
Biotech giant's top dealmaker says he's focusing on early-stage drugs.
May 07, 2007 - Business - Dealmaking
.gif)
.png){kind=small} |
 |